Wednesday, August 25, 2021

Has This Safety Monitoring Been Done? If So, What Were The Results?

FDA  | From Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization Review Memorandum  - Page 44


5.2. Pharmacovigilance Activities
Pfizer submitted a Pharmacovigilance Plan (PVP) to monitor safety concerns that could be associated with Pfizer-BioNTech COVID-19 Vaccine. The Sponsor identified vaccine-associated enhanced disease including vaccine-associated enhanced respiratory disease as an important potential risk.


0 comments:

bonjour bonne annΓ©e...,

2025 is a mathematical wonder.!! pic.twitter.com/WsUfhKF4C9 — π—Ÿ 𝗼 𝗹 𝗹 π˜‚ 𝗯 𝗲 𝗲 (@Lollubee) December 30, 2024